Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer Sells 3,655 Shares

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer sold 3,655 shares of the firm’s stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the transaction, the director now directly owns 287,307 shares in the company, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Calumet Specialty Products Partners Price Performance

Calumet Specialty Products Partners stock opened at $12.23 on Thursday. Calumet Specialty Products Partners, L.P. has a 1 year low of $9.97 and a 1 year high of $25.29. The firm’s 50 day moving average price is $14.92 and its 200-day moving average price is $18.50. The stock has a market cap of $1.05 billion, a P/E ratio of -4.43 and a beta of 1.88.

Calumet Specialty Products Partners (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million during the quarter, compared to the consensus estimate of $921.76 million. During the same quarter in the prior year, the firm posted ($0.59) earnings per share. The business’s revenue was down 2.8% on a year-over-year basis. As a group, equities analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CLMT shares. UBS Group raised shares of Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and reduced their target price for the stock from $15.00 to $12.00 in a report on Monday, March 17th. HC Wainwright reissued a “buy” rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen cut shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and lowered their target price for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Finally, Wells Fargo & Company cut their price target on Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Calumet Specialty Products Partners presently has an average rating of “Hold” and a consensus target price of $20.80.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.